申请人:Incyte Corporation
公开号:US10947227B2
公开(公告)日:2021-03-16
The present application provides tricyclic heterocyclic compounds that activate the STING pathway to produce interferons, which are useful in the treatment of various diseases including infectious diseases and cancer.
本申请提供的三环杂环化合物可激活 STING 通路产生干扰素,而干扰素可用于治疗各种疾病,包括传染病和癌症。